SCHEMBL7140551

SCHEMBL7140551

CC(C)(C)OC(=O)Nc1cc(COC2CCCCO2)c(I)cc1[N+](=O)[O-]

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 2/20 0.36
CREBBP Q92793 2/20 0.36
MAPT P10636 7/20 0.36
ALDH1A1 P00352 7/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
HPGD P15428 2/20 0.35
KMT2A Q03164 6/20 0.34
MEN1 O00255 4/20 0.34
MAPK1 P28482 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
EP300 Q09472 1/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
THRB P10828 1/20 0.33
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7698563 0.89 HCAR3 (0.40) HCAR3CREBBPMAPTALDH1A1L3MBTL1
SCHEMBL5563454 0.88 KMT2A (0.38) HCAR3CREBBPMAPTALDH1A1L3MBTL1
SCHEMBL7143475 0.85 KMT2A (0.35) HCAR3CREBBPMAPTALDH1A1L3MBTL1
SCHEMBL7139585 0.84 MMP8 (0.35) HCAR3CREBBPMAPTALDH1A1L3MBTL1
SCHEMBL7139514 0.83 CHRM3 (0.35) HCAR3CREBBPMAPTALDH1A1L3MBTL1
SCHEMBL7145353 0.83 HCAR3 (0.33) HCAR3CREBBPMAPTALDH1A1L3MBTL1
SCHEMBL7147995 0.82 ALDH1A1 (0.36) HCAR3CREBBPMAPTALDH1A1L3MBTL1
SCHEMBL7147347 0.81 MAPT (0.36) HCAR3MAPTALDH1A1L3MBTL1KMT2A
SCHEMBL7145150 0.81 ADRA2A (0.35) HCAR3CREBBPMAPTALDH1A1L3MBTL1
SCHEMBL7143075 0.80 MAPT (0.35) HCAR3MAPTALDH1A1L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed